Outset Medical Inc (OM)
2.66
+0.12
(+4.72%)
USD |
NASDAQ |
May 01, 11:14
Outset Medical SG&A Expense (Quarterly): 32.53M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 32.53M |
September 30, 2023 | 36.54M |
June 30, 2023 | 36.28M |
March 31, 2023 | 36.12M |
December 31, 2022 | 33.65M |
September 30, 2022 | 32.28M |
June 30, 2022 | 33.98M |
March 31, 2022 | 30.09M |
December 31, 2021 | 32.71M |
Date | Value |
---|---|
September 30, 2021 | 23.36M |
June 30, 2021 | 22.93M |
March 31, 2021 | 22.40M |
December 31, 2020 | 24.25M |
September 30, 2020 | 26.43M |
June 30, 2020 | 14.09M |
March 31, 2020 | 10.81M |
December 31, 2019 | 9.161M |
September 30, 2019 | 7.448M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
7.448M
Minimum
Sep 2019
36.54M
Maximum
Sep 2023
25.84M
Average
28.26M
Median
SG&A Expense (Quarterly) Benchmarks
AngioDynamics Inc | 35.98M |
Baxter International Inc | 935.00M |
Allurion Technologies Inc | 26.10M |
Perspective Therapeutics Inc | 1.694M |
Xtant Medical Holdings Inc | 20.45M |